EVE Health Group Limited (ASX: EVE) — Consumer Defensive · Share Price, Chart & Market Data
About: EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction. It also offers Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.
Sector: Consumer Defensive
Industry: Packaged Foods
Latest price: A$0.03 (-3.23%)
EVEEVE Health Group Limited
Loading watchlist status…
Trade EVE now
EVE Health Group Limited share price
EVE price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:27 am GMT+0
EVE price performance
-3.226%
5D
50%
1M
50%
YTD
-25%
1Y
EVE price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:27 am GMT+0
EVE details
EVE Market Signals